TLA Technology: a new DNA diagnostic test to sequence genes that cause the disease and detect new mutations: proof of concept study voor patients with Rendu-Osler-Weber disease.
Completed
- Conditions
- 10007510Rendu-Osler-Weber hereditary hemorrhagic telangiectasia
- Registration Number
- NL-OMON39779
- Lead Sponsor
- Sint Antonius Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 45
Inclusion Criteria
Patient with Rendu Osler Weber disease who didn't have a mutation tested in the previous testmethod
Patients with known ENG or ALK mutation
Exclusion Criteria
Patients without ROW
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>See study objectives</p><br>
- Secondary Outcome Measures
Name Time Method <p>NA</p><br>